Drug factory · FDA FEI 3003346516

Biocodex

1 avenue Blaise Pascal, Beauvais, France

France: 1

Problems found, fixed voluntarily at FDA's last inspection, Jun 17, 2022.

Voluntary Action Indicated: inspectors found problems, but not serious enough for FDA to take action. The company is expected to fix them.

3 drug inspections on record since 2016: 1 with no problems, 2 with problems fixed voluntarily, 0 with FDA action.

What it does, for whom

DrugRoleForNDC
StiripentolMakes it Biocodex, Inc. 68418-7939, 68418-7940, 68418-7941 +1

FDA inspection history

EndedResultProgramProblems noted
Jun 17, 2022Problems found, fixed voluntarilyDrug Quality Assurance—
Jan 23, 2020Problems found, fixed voluntarilyDrug Quality Assurance—
Sep 16, 2016No problems foundBioresearch Monitoring—

Registered with FDA for: analysis; api manufacture; label; manufacture; pack; relabel; repack.